Medical Services Revenue was Agilon Health’s largest product and service line in fiscal 2025, bringing in $5.92B of $5.93B (100%).
| Product and Service | FY 2019 | FY 2020 | FY 2021 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|
| Medical Services Revenue | $4.31B | $6.05B | $5.92B | |||
| Medical Services | — | — | — | |||
| Other Operating Revenue | $9.01M | $12.82M | $11.24M | |||
| Other Operating | — | — | — | |||
| Total | $4.32B | $6.06B | $5.93B |
Agilon Health brought in $5.93B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 2.1% from $6.06B in fiscal 2024. Medical Services Revenue was the largest at $5.92B (99.8%), ahead of Other Operating Revenue at $11.24M (0.2%).
From fiscal 2023 to 2025, combined revenue from these lines grew from $4.32B to $5.93B, a compound annual growth rate of 17.2%. Medical Services Revenue's share held steady at about 99.8%.
Agilon Health (AGL) reports its revenue by product and service. In fiscal 2025, Medical Services Revenue was its largest product and service line, bringing in $5.92B (99.8% of the total), followed by Other Operating Revenue at $11.24M (0.2%).
Medical Services Revenue was Agilon Health's largest product and service line in fiscal 2025, bringing in $5.92B, or 99.8% of the $5.93B total across its two product and service lines.
Every figure comes from Agilon Health's annual financial filings, as reported. Each line keeps the name Agilon Health gives it, and years follow its fiscal calendar.
Agilon Health's revenue by product and service goes back to fiscal 2019, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.